Akiko Omori

724 citations
32 papers · 553 indexed · h-index 10
Topics
Hepatocellular Carcinoma Treatment and Prognosis (5 papers)Urological Disorders and Treatments (4 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers)
Journals
SHILAP Revista de lepidopterologíaBiochemistryAnnals of Surgery
Partner nations
JapanItalyPhilippines

In The Last Decade

Akiko Omori

27 papers receiving 543 citations

Peers

Akiko Omori
Comparison fields: 5 of 87
  • Molecular Biology 278
  • Plant Science 108
  • Urology 84
  • Surgery 74
  • Biochemistry 53
Replace Meifang Chen with:
Meifang Chen China
Tian China
Haiyan Qin China
Shenpei Liu China
Walaa A. Keshk Egypt
Sibel Dinçer Türkiye
Youyou Li China
Lise Sofie Haug Nissen‐Meyer Norway
Anandharajan Rathinasabapathy United States
Akiko Omori relative to Meifang Chen China Meifang Chen's profile →
Citations per field
00.5×
Meifang Chen · 1×
Citations per year

Countries citing papers authored by Akiko Omori

Since Specialization
Citations

This map shows the geographic impact of Akiko Omori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Omori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Omori more than expected).

Fields of papers citing papers by Akiko Omori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Omori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Omori. The network helps show where Akiko Omori may publish in the future.

Co-authorship network of co-authors of Akiko Omori

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Omori. A scholar is included among the top collaborators of Akiko Omori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Omori. Akiko Omori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 1
4 1
5 3
6 4
7 6
8 9
9 1
10 17
11 76
12 3
13 1
14 8
15 8
16 4
17 6
18 26
19 6
20 137

About Akiko Omori

Akiko Omori is a scholar working on Hepatology, Health Informatics and Urology, having authored 32 papers that have together received 553 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Urological Disorders and Treatments (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Urology (84 citations), Biochemistry (53 citations) and Hepatology (45 citations). Akiko Omori has collaborated with scholars based in Japan, Italy and Philippines. Frequent co-authors include Gen Yamada, Johannes Burtscher, Takumi Koshiba, Giuseppe Cappellano, Grégoire P. Millet, Yasushi Ohizumi, Tohru Yamakuni, Takeshi Tadano, Naomi Nakagata and Yoshihiro Mimaki. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemistry and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026